Illumina
ILMN
$0.27 (-0.20%)
1D
1W
3M
1Y
5Y
ALL
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 22 days ago • ILMN
11 Ultra SWAN Bargains That Could Thrive As The Market Soars To Record HighsPRNewsWire • 23 days ago • ILMN
Illumina To Webcast Upcoming Investor ConferencePRNewsWire • 23 days ago • ILMN
Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing ApplicationsSeeking Alpha • 24 days ago • ILMN
Illumina, Inc. (ILMN) CFO Ankur Dhingra Hosts Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)Seeking Alpha • about a month ago • ILMN
Illumina, Inc. (ILMN) CFO Ankur Dhingra Hosts Wolfe Research 2024 Healthcare Conference (Transcript)Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.